According to ImmunoPrecise Antibodies's latest financial reports the company has a price-to-book ratio of 0.7079.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | N/A | -100% |
2023-12-31 | 1.20 | -58.23% |
2022-12-31 | 2.86 | 13.02% |
2021-12-31 | 2.53 | -76.56% |
2020-12-31 | 10.8 | 300.49% |
2019-12-31 | 2.70 | 23.92% |
2018-12-31 | 2.18 | -18.2% |
2017-12-31 | 2.66 | -95.55% |
2016-12-31 | 59.8 | -96682.4% |
2015-12-31 | -0.0619 | -93.58% |
2014-12-31 | -0.9644 | 194.99% |
2013-12-31 | -0.3269 | |
2012-12-31 | N/A | -100% |
2011-12-31 | -5.16 | -133.05% |
2010-12-31 | 15.6 | 2821.91% |
2009-12-31 | 0.5346 | |
2008-12-31 | N/A | |
2007-12-31 | N/A | |
2006-12-31 | N/A | |
2005-12-31 | N/A | |
2004-12-31 | N/A | |
2003-12-31 | N/A | |
2002-12-31 | N/A |